Zydus Wellness Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Zydus Wellness de 19.4% y 10.4% por año respectivamente. Se prevé que el BPA crezca en un 19.1% al año. Se espera que la rentabilidad financiera sea de 7.7% en 3 años.

Información clave

19.4%

Tasa de crecimiento de los beneficios

19.1%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Food	21.2%
Tasa de crecimiento de los ingresos	10.4%
Rentabilidad financiera futura	7.7%
Cobertura de analistas	Good
Última actualización	12 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

With EPS Growth And More, Zydus Wellness (NSE:ZYDUSWELL) Makes An Interesting Case

Jun 20

Zydus Wellness (NSE:ZYDUSWELL) Has Announced A Dividend Of ₹5.00

May 20

Zydus Wellness Limited (NSE:ZYDUSWELL) Shares Could Be 25% Above Their Intrinsic Value Estimate

May 18

Here's Why We Think Zydus Wellness (NSE:ZYDUSWELL) Is Well Worth Watching

Mar 07

Is Zydus Wellness Limited (NSE:ZYDUSWELL) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 07

We Think Zydus Wellness (NSE:ZYDUSWELL) Can Manage Its Debt With Ease

Jan 19

Does Zydus Wellness (NSE:ZYDUSWELL) Deserve A Spot On Your Watchlist?

Dec 03

Is Zydus Wellness (NSE:ZYDUSWELL) Using Too Much Debt?

Sep 28

Here's Why Zydus Wellness Limited's (NSE:ZYDUSWELL) CEO Compensation Is The Least Of Shareholders Concerns

Jul 23

Is Zydus Wellness (NSE:ZYDUSWELL) A Risky Investment?

Mar 09

What To Know Before Buying Zydus Wellness Limited (NSE:ZYDUSWELL) For Its Dividend

Feb 16

If You Had Bought Zydus Wellness (NSE:ZYDUSWELL) Shares Five Years Ago You'd Have Earned 156% Returns

Jan 26

Has Zydus Wellness Limited's (NSE:ZYDUSWELL) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Jan 05

Need To Know: Zydus Wellness Limited (NSE:ZYDUSWELL) Insiders Have Been Buying Shares

Dec 15

Here's Why Zydus Wellness (NSE:ZYDUSWELL) Can Manage Its Debt Responsibly

Nov 24

Is Zydus Wellness Limited (NSE:ZYDUSWELL) The Right Choice For A Smart Dividend Investor?

Jul 15

Previsiones de crecimiento de beneficios e ingresos

NSEI:ZYDUSWELL - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2027	31,251	5,319	4,313	N/A	1
3/31/2026	28,723	4,037	3,258	N/A	4
3/31/2025	26,270	3,949	3,461	N/A	6
3/31/2024	23,187	2,905	3,522	N/A	3
12/31/2023	22,581	2,619	N/A	N/A	N/A
9/30/2023	22,713	2,812	744	1,165	N/A
6/30/2023	22,605	2,838	N/A	N/A	N/A
3/31/2023	22,548	3,104	468	917	N/A
12/31/2022	21,816	2,983	N/A	N/A	N/A
9/30/2022	21,541	3,021	1,553	2,034	N/A
6/30/2022	21,083	3,151	N/A	N/A	N/A
3/31/2022	20,091	3,089	1,614	2,369	N/A
12/31/2021	19,751	3,087	N/A	N/A	N/A
9/30/2021	19,685	2,871	2,009	2,576	N/A
6/30/2021	19,269	1,603	N/A	N/A	N/A
3/31/2021	18,667	1,187	2,671	2,867	N/A
12/31/2020	17,488	547	N/A	N/A	N/A
9/30/2020	16,999	572	2,116	2,362	N/A
6/30/2020	16,839	1,505	N/A	N/A	N/A
3/31/2020	17,668	1,417	2,346	2,593	N/A
12/31/2019	16,951	1,349	N/A	N/A	N/A
9/30/2019	15,078	1,704	2,954	3,186	N/A
6/30/2019	13,200	2,238	N/A	N/A	N/A
3/31/2019	8,428	1,691	1,323	1,494	N/A
12/31/2018	5,489	1,431	N/A	N/A	N/A
9/30/2018	5,359	1,396	N/A	N/A	N/A
6/30/2018	5,212	1,344	N/A	N/A	N/A
3/31/2018	5,126	1,339	612	691	N/A
12/31/2017	4,851	1,274	N/A	N/A	N/A
9/30/2017	4,558	1,164	N/A	N/A	N/A
6/30/2017	4,373	1,122	N/A	N/A	N/A
3/31/2017	4,306	1,090	N/A	770	N/A
12/31/2016	4,484	1,063	N/A	N/A	N/A
9/30/2016	4,488	1,086	N/A	N/A	N/A
6/30/2016	4,414	1,056	N/A	N/A	N/A
3/31/2016	3,967	1,033	N/A	899	N/A
12/31/2015	4,171	961	N/A	N/A	N/A
9/30/2015	4,361	1,132	N/A	N/A	N/A
6/30/2015	4,338	1,114	N/A	N/A	N/A
3/31/2015	4,307	1,090	N/A	692	N/A
12/31/2014	4,188	1,105	N/A	N/A	N/A
9/30/2014	4,024	929	N/A	N/A	N/A
6/30/2014	3,970	908	N/A	N/A	N/A
3/31/2014	4,036	965	N/A	911	N/A
12/31/2013	4,058	1,121	N/A	N/A	N/A
9/30/2013	4,044	1,079	N/A	N/A	N/A
6/30/2013	3,982	1,063	N/A	N/A	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (19.4% al año) de ZYDUSWELL es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Se prevé que los beneficios (19.4% al año) de ZYDUSWELL crezcan más rápidamente que el mercado Indian (17.8% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de ZYDUSWELL crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (10.4% al año) de ZYDUSWELL crezcan más rápidamente que los del mercado Indian (10.3% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 10.4% al año) de ZYDUSWELL crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de ZYDUSWELL sea baja dentro de 3 años (7.7%).

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Zydus Wellness Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased by 7.4% to ₹1,813

Price target decreased to ₹2,125

Price target decreased to ₹2,339

Price target increased to ₹2,517

Price target raised to ₹2,266

Price target raised to ₹2,039

Recent updates

Is Zydus Wellness (NSE:ZYDUSWELL) Using Too Much Debt?

Insider recently bought ₹175m worth of stock

Third quarter 2024 earnings released: EPS: ₹0.05 (vs ₹3.07 in 3Q 2023)

Zydus Wellness Limited to Report Q3, 2024 Results on Feb 08, 2024

Second quarter 2024 earnings released: EPS: ₹0.93 (vs ₹1.33 in 2Q 2023)

Zydus Wellness Limited Announces Resignation of Savyasachi Sengupta as Independent Director

Zydus Wellness Limited to Report Q2, 2024 Results on Nov 06, 2023

Insider recently bought ₹331m worth of stock

Zydus Wellness Limited Approves Final Dividend for the Financial Year Ended March 31, 2023

New minor risk - Dividend sustainability

Zydus Wellness Limited to Report Q1, 2024 Results on Aug 03, 2023

Upcoming dividend of ₹5.00 per share at 0.3% yield

Full year 2023 earnings: EPS misses analyst expectations

Zydus Wellness (NSE:ZYDUSWELL) Has Announced A Dividend Of ₹5.00

Insider recently bought ₹385m worth of stock

Insider recently bought ₹148m worth of stock

Price target decreased by 7.4% to ₹1,813

Zydus Wellness (NSE:ZYDUSWELL) Is Paying Out A Dividend Of ₹5.00

Zydus Wellness Limited, Annual General Meeting, Aug 03, 2023

Zydus Wellness Limited Appoints Akhil Monappa as Additional Director (Non Executive & Independent Director)

Full year 2023 earnings: EPS misses analyst expectations

Zydus Wellness Limited, Annual General Meeting, Aug 03, 2023

Insider recently bought ₹1.8m worth of stock

Third quarter 2023 earnings released: EPS: ₹3.07 (vs ₹3.66 in 3Q 2022)

CEO & Whole Time Director recently bought ₹301k worth of stock

Zydus Wellness (NSE:ZYDUSWELL) Has A Pretty Healthy Balance Sheet

Insufficient new directors

Insider recently bought ₹16m worth of stock

Insider recently bought ₹9.2m worth of stock

Zydus Wellness Limited Declares Final Dividend for the Financial Year Ended March 31, 2022

Zydus Wellness Limited Appoints Nandish P. Joshi as the Company Secretary

Upcoming dividend of ₹5.00 per share

Zydus Wellness Limited to Report First Half, 2023 Results on Nov 14, 2022

Zydus Wellness (NSE:ZYDUSWELL) Has Announced A Dividend Of ₹5.00

With EPS Growth And More, Zydus Wellness (NSE:ZYDUSWELL) Makes An Interesting Case

Insider recently bought ₹55m worth of stock

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Zydus Wellness (NSE:ZYDUSWELL) Has Announced A Dividend Of ₹5.00

Zydus Wellness Limited Recommends Final Dividend for the Year Ended on March 31, 2022, Payable on or After August 4, 2022

Zydus Wellness Limited (NSE:ZYDUSWELL) Shares Could Be 25% Above Their Intrinsic Value Estimate

Zydus Wellness Limited, Annual General Meeting, Jul 29, 2022

Insufficient new directors

Price target decreased to ₹2,125

Insufficient new directors

Here's Why We Think Zydus Wellness (NSE:ZYDUSWELL) Is Well Worth Watching

Insider recently bought ₹757k worth of stock

Zydus Wellness Limited Announces Resignation of Dhanraj P. Dagar as Company Secretary & Compliance Officer, Effective May 10, 2022

Price target decreased to ₹2,339

Is Zydus Wellness Limited (NSE:ZYDUSWELL) Expensive For A Reason? A Look At Its Intrinsic Value

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

We Think Zydus Wellness (NSE:ZYDUSWELL) Can Manage Its Debt With Ease

Does Zydus Wellness (NSE:ZYDUSWELL) Deserve A Spot On Your Watchlist?

CEO & Whole Time Director recently bought ₹812k worth of stock

Second quarter 2022 earnings released: EPS ₹3.37 (vs ₹18.14 loss in 2Q 2021)

Is Zydus Wellness (NSE:ZYDUSWELL) Using Too Much Debt?

Insider recently sold ₹2.3m worth of stock

Here's Why Zydus Wellness Limited's (NSE:ZYDUSWELL) CEO Compensation Is The Least Of Shareholders Concerns

Price target increased to ₹2,517

Upcoming dividend of ₹5.00 per share

Full year 2021 earnings released: EPS ₹19.55 (vs ₹24.58 in FY 2020)

Full year 2021 earnings released: EPS ₹19.55 (vs ₹24.58 in FY 2020)

Zydus Wellness Limited Recommends Final Dividend

Is Zydus Wellness (NSE:ZYDUSWELL) A Risky Investment?

What To Know Before Buying Zydus Wellness Limited (NSE:ZYDUSWELL) For Its Dividend

Price target raised to ₹2,266

Third quarter 2021 earnings released: EPS ₹0.27 (vs ₹0.73 in 3Q 2020)

Revenue beats expectations, earnings disappoint

Zydus Announces United States Food and Drug Administration (USFDA) Has Granted `Orphan Drug Designation' (ODD) to Saroglitazar Mg for the Treatment of Patients with Primary Biliary Cholangitis

If You Had Bought Zydus Wellness (NSE:ZYDUSWELL) Shares Five Years Ago You'd Have Earned 156% Returns